ELAB vs PLD · rev $2.0M vs P/E 27, rev $2.30B
Elevai Labs, Inc. Common Stock (ELAB) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported PLD revenue for 2026-03-31 was $2.30B. Net income was $982.0M. Revenue was up 2.0% from 2025-12-31 to 2026-03-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
ELAB currently screens at market cap $6.5M. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the ELAB and PLD stock pages for the full models.
Not investment advice.